Anzeige
Mehr »
Donnerstag, 12.02.2026 - Börsentäglich über 12.000 News
Drohnen, Robotik, E-Autos: Diese Hightech-Aktie könnte jetzt zünden
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
170 Leser
Artikel bewerten:
(0)

EchoNous Unveils Kosmos Plus: Giving Hospitals a Low-Cost Alternative to Expensive Ultrasound Carts Without Compromising on Image Quality or Advanced Capabilities

REDMOND, WA / ACCESSWIRE / November 8, 2023 / EchoNous, the company at the forefront of premium handheld point-of-care ultrasound (POCUS) technology, today unveiled Kosmos® Plus, its latest innovation designed to replace costly POCUS carts. EchoNous continues its tradition of redefining POCUS, making high-performance, diagnostic-grade ultrasound imaging more accessible and user-friendly without compromising on quality.

Kosmos Plus

Kosmos Plus
The two-plus probe ultrasound imaging system in use

Kosmos Plus offers a comprehensive, two-plus probe ultrasound imaging solution for less than $20,000 in a marketplace where comparable systems cost twice as much or more. Integrating a suite of advanced capabilities, including cutting-edge AI, advanced Doppler features, various transducers, a 12.9-inch iPad Pro® display, and a medical-grade stand, this turnkey solution is poised to revolutionize the POCUS landscape. Now, clinicians will have the advanced capabilities of a full-featured POCUS cart at a fraction of the cost.

"In the ED, 90% of our POCUS exams are abdominal, lung, cardiac or guided vascular access procedures," said Dr. Mark Favot, Associate Professor at Wayne State University and Director of Emergency Medicine Ultrasound Education at Sinai-Grace Hospital/Detroit Medical Center. "Not only can the Kosmos transducers and features easily satisfy those needs, but the AI on the system provides additional assistance for novice users and helps improve our efficiency when it comes to quickly calculating an ejection fraction," Favot continued.

Among the features that set the Kosmos Plus apart include:

AI-Enhanced POCUS for Next-Level Clinical Insights. Kosmos Plus is embedded with EchoNous' pioneering AI features, including Trio, which simplifies cardiac examination with AI-driven guidance, grading, and labeling. AI FAST and the AI-assisted EF Workflow further streamline the imaging process, offering AI-driven anatomical labeling, view identification, ejection fraction, and stroke volume calculations. These integrated AI capabilities are designed to augment clinical decisions, ensuring high precision and efficiency in patient care.

Expanding Capabilities With Advanced Doppler Features. The introduction of Color Doppler, PW, TDI, and CW Doppler to Kosmos Plus enhances the clinician's ability to perform comprehensive vascular and cardiac assessments. These features, coupled with the system's flexibility and ease of use, solidify EchoNous' commitment to providing cutting-edge tools that advance the field of ultrasound diagnostics.

Customizable and Clinician-Centered. EchoNous has meticulously crafted Kosmos Plus to meet the varying needs of point-of-care clinicians. With all components provided in one package, there's no need to secure different elements from multiple suppliers: everything is in one box and ready to go. With flexible probe configurations, including Torso-One, Lexsa or both, and the ability to connect both probes simultaneously and charge while scanning, clinicians can tailor their workflow and diagnostic approach to patient needs. The Kosmos Medical-Grade Stand ensures mobility and readiness while also demonstrating EchoNous' dedication to creating solutions as practical as they are powerful.

A Commitment to Clinical Excellence and Innovation. EchoNous' CEO Graham Cox remarks on the launch. "With Kosmos Plus, we're not just delivering a product; we're enhancing the entire ecosystem of point-of-care diagnostics. Our relentless drive for innovation and refusal to compromise on quality culminates in this significant milestone. Kosmos Plus represents a leap forward in our mission to make POCUS more capable, accessible, and intuitive for every clinician."

To explore how Kosmos Plus can transform your practice, visit EchoNous.com/KosmosPlus.

About EchoNous

Based in Redmond, Washington, EchoNous is reshaping the landscape of point-of-care ultrasound with every innovation. By fusing unparalleled ultrasound performance with industry-leading AI, EchoNous provides clinicians with rapid, accurate insights, improving patient outcomes across healthcare environments. For more information, visitwww.echonous.com.

Media inquiries:
Luke Baldwin
VP, Global Marketing
luke.baldwin@echonous.com

Contact Information

Fernando Nuñez
PR Manager
fernando@intelligentrelations.com
+593979074434

SOURCE: EchoNous

.

View source version on accesswire.com:
https://www.accesswire.com/800976/echonous-unveils-kosmos-plus-giving-hospitals-a-low-cost-alternative-to-expensive-ultrasound-carts-without-compromising-on-image-quality-or-advanced-capabilities

© 2023 ACCESS Newswire
Favoritenwechsel
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.